000 01514 a2200397 4500
005 20250518010818.0
264 0 _c20190418
008 201904s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2018.11.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDorasamy, Mathura Subangari
245 0 0 _aSynergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cFeb 2019
300 _a29-36 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aBiphenyl Compounds
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Synergism
650 0 4 _aHumans
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
_xmethods
700 1 _aAb, Aravind
700 1 _aNellore, Kavitha
700 1 _aWong, Pooi-Fong
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 110
_gp. 29-36
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2018.11.010
_zAvailable from publisher's website
999 _c29073022
_d29073022